Navigation Links
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Date:10/26/2007

es of Health (NIH), ADHD is one of the most common mental disorders in childhood. It affects an estimated four million children and adolescents in the United States. Although once considered to be a disorder only seen in children, ADHD is now known to be a common neuropsychiatric disorder associated with a wide range of functional impairments throughout the lifespan, according to the Journal American Occupational Environmental Medicine (Kessler, RC et al 2005.)

About CONCERTA(R)

CONCERTA(R) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages six-17. For more information about CONCERTA(R), including full U.S. prescribing information, please visit http://www.concerta.net, call 1-888-440-7903 or contact your health care provider.

Important Safety Information

CONCERTA(R) should not be taken by patients with: significant anxiety, tension or agitation; allergies to methylphenidate or other ingredients in CONCERTA(R); glaucoma; Tourette's syndrome, tics or family history of Tourette's syndrome. Abuse of methylphenidate may lead to dependence. Tell your health care professional if your child has had problems with alcohol or drugs, has had depression, abnormal thoughts or visions, bipolar disorder, seizures, high blood pressure or has had any heart problems or defects. If your child develops abnormal thinking or hallucinations, abnormal, extreme moods and/or excessive activity, or if aggressive behavior or hostility develops or worsens while taking CONCERTA(R), consult your health care professional. The most common adverse events reported in children receiving up to 54 mg were headache, upper respiratory tract infection and abdominal pain. The most common adverse events reported by adolescents receiving up to 72 mg were headache, accidental injury and insomnia.

About McNeil Pediatrics

McNeil Pediatrics Division of McNeil-PPC,
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Northstar Global Business Services, Inc. (OTCPink:MDIN) ... has made their final decision and has determined ... stock effective December 15, 2014, and has resumed ... and book entry transfer services. All deposit restrictions have ... again fully "DTC Eligible", and has resumed electronic ...
(Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... applications made a lot of progress in the ... are now accepted in high-reliability environments, and are ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... , March 15 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ... a conference call at 10:00 a.m. Eastern Time ... financial results for the first quarter,of its fiscal year ...
... announced today that it has finalized an amendment to its loan and security agreement with Silicon Valley Bank.  The amendment extends the ... to obtain additional funds if necessary. , ... , ... ...
Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 3Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 2Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 3
(Date:12/15/2014)... Cancer researchers have just published an important ... deadly malignant pleural mesothelioma. Surviving Mesothelioma has just posted ... Click here to read it now. , Doctors ... and New York’s Langone Medical Center performed complete genetic ... in an effort to pinpoint the genes that are ...
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... (HealthDay News) -- Expert pilots process visual information more ... make better decisions during landings, a new study shows. ... for pilots to master, and 36 percent of all ... during final approach and landing. Researchers monitored the ... experienced pilots while they were at the controls of ...
(Date:12/15/2014)... In support of high-quality independent ... restrictive state laws that may have unintended consequences ... area of public health policy. , The position ... of Independent Review, contends that state legislation that ... review determinations can result in subpar outcomes for ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 For the second ... Coffee Review “Top 30 Coffees of 2014.” Bird Rock Coffee ... their Guji Zone Ethiopia at number 10. This is the ... , Coffee Review’s selection is ranked on quality, value, and ... Batak scored 96 out of 100, and at $17.99 for ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... Serena Gordon HealthDay Reporter , TUESDAY, March 8 ... an increased risk of dying, even as long as three ... Those who are discharged from the hospital to a skilled ... according to the study. People between 31 and 65 who ...
... -- Treatment for drug addiction is affected by a person,s ... report. A research team at the Brookhaven National Laboratory ... have lower gray matter density -- and therefore fewer neurons ... decision-making, self-control, learning and memory. "This research shows that ...
... many hours we spend in light, dreamless slumber. But a ... busy recharging our brain,s learning capacity during this traditionally undervalued ... UC Berkeley researchers have found compelling evidence that ... networking between key regions of the brain to clear a ...
... Fla. The Pancreatic Cancer Action Network and the ... Bailey, Ph.D., and E. Scott Seeley, M.D., Ph.D., the ... Leadership Grants. These grants, each totaling $600,000 over five ... Annual Meeting 2011, held April 2-6. "Because of ...
... A prolific University of Missouri chemist has discovered ... make certain drugs. Jerry Atwood, Curator,s Professor and ... College of Arts and Science, has recently published a ... that states that highly pressurized carbon dioxide at room ...
... VA The National Comprehensive Cancer Network (NCCN), and ... announce a collaboration to advance research for cancer imaging ... qualify imaging sites for upcoming research projects utilizing molecular ... Research Program (ORP), obtains funding to support scientifically meritorious ...
Cached Medicine News:Health News:Risk of Death May Linger for Trauma Survivors 2Health News:Risk of Death May Linger for Trauma Survivors 3Health News:Genes May Affect Severity of Drug Addiction 2Health News:As we sleep, speedy brain waves boost our ability to learn 2Health News:As we sleep, speedy brain waves boost our ability to learn 3Health News:PanCan-AACR Pathway to Leadership grants awarded 2Health News:PanCan-AACR Pathway to Leadership grants awarded 3Health News:PanCan-AACR Pathway to Leadership grants awarded 4Health News:MU chemist discovers shortcut for processing drugs 2Health News:National Comprehensive Cancer Network and SNM join to advance oncology imaging research 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: